Sciomics: Enabling precision medicine

Info

Enabling Precision Medicine through Advanced Protein Biomarkers.

Geschichte

We support and speed up Protein Biomarker Research and Discovery Programmes for Precision Medicine and Companion Diagnostic applications. Based on our unique antibody microarray platform we reduce costs and attrition rates for biomarker identification and verification projects and provide comprehensive protein expression level analysis.

Based on our proprietory system for highly-parallel protein analyses, we established a broad internal biomarker development pipeline for oncological indications as well as kidney injury. These newly developed biomarker signatures enable a precise diagnosis and patient stratification leading to a precise therapy adapted to the individual patient needs.

"Protein profiling plays an essential part in today’s biomedical research, striving to improve patients’ quality of life by using molecular signatures for diagnosis and treatment guidance. At Sciomics, we believe that our explorative proteomic and post-translational modification profiling platform enables true progress in precision medicine. Therefore, our internal development pipeline of innovative biomarker signatures for precision medicine is based on this powerful platform. In addition, we offer services based on our scioDiscover platform and R&D collaborations for the discovery of novel biomarkers, drug target screening, the characterization of disease models, and for the analysis of pathway activity as as mode-of-action studies."